Stryker to Acquire Digital Care Platform Vocera Communications for Nearly $3 Billion

By MedTech Intelligence Staff

“The deal will help Stryker significantly accelerate [its] digital aspirations to improve the lives of caregivers and patients,” according to company Chair and CEO Kevin Lobo.

Today Stryker announced a definitive merger agreement to acquire Vocera Communications for $3.09 billion. Vocera provides a platform for digital care coordination and communication strategy, offering a portfolio that is complementary to Stryker’s division that focuses on technologies that address connecting hospitals with caregivers, and data-generating medical devices. “Vocera’s highly developed software competency, unique and innovative hardware solutions, and the ability to securely enable remote communication between patients and their families, complements Stryker’s Advanced Digital Healthcare offerings,” according to a Vocera press release. “The combined business will further advance Stryker’s focus on preventing adverse events throughout the continuum of care.”

“This acquisition underscores our commitment and focus on our customer,” stated Kevin Lobo, chair and CEO of Stryker. “Vocera will help Stryker significantly accelerate our digital aspirations to improve the lives of caregivers and patients.”

The acquisition is expected to close in the first quarter of this year.

Related Articles

  • AMA Logo

    The blueprint includes opportunities for various healthcare stakeholders to contribute to the full optimization of digitally enabled care and includes case examples featuring organizations with care models that leverage the blueprint’s six pillars. 

  • Bernstein_Mazur

    Rapid developments in healthcare technology, combined with improved data collection, pandemic pressures and increased consumer demand for tech-enabled and virtual health care, are fueling innovation and transformation in the digital health space.

  • Rogers-Headshot

    Digital therapeutics (DTx) have the potential to lower healthcare costs and improve patient compliance, outcomes and access to care. In the first part of this two-article series we look at the current and potential applications for this growing sector of…

  • Kaushik Gune

    This week Huma Therapeutics received FDA Class II 510(k) clearance for its Software as a Medical Device (SaMD) platform, potentially speeding approval of a variety of AI and machine-learning (ML)-powered digital health devices. We spoke with Kaushik Gune, U.S. Head…

About The Author

MedTech Intelligence